AssetMark to Announce Fourth Quarter 2022 Results on February 22, 2023
Get Alerts AMK Hot Sheet
Join SI Premium – FREE
CONCORD, Calif., Feb. 10, 2023 (GLOBE NEWSWIRE) -- AssetMark Financial Holdings, Inc. (NYSE: AMK) today announced that it will release financial results for its quarter ended December 31, 2022, after the U.S. market close on Wednesday, February 22, 2023. AssetMark will host a conference call and webcast that day at 5:00 pm ET to discuss its results.
AssetMark invites shareholders and other interested parties to listen to its financial results conference call live, either over the Internet or via dial-in.
Listeners can access the webcast at the AssetMark Investor Relations website at ir.assetmark.com.
Alternatively, listeners can pre-register for the conference call here: https://www.netroadshow.com/events/login?show=5acca13d&confId=46295. Upon registering, you will be provided with participant dial-in numbers, passcode and unique registrant ID. In the 10 minutes prior to the call start time, you may use the conference access information (dial-in number, direct event passcode, and registrant ID) provided in the confirmation email received at the point of registering to join the call directly.
About AssetMark Financial Holdings, Inc.
AssetMark is a leading provider of extensive wealth management and technology solutions that power independent financial advisors and their clients. Through AssetMark, Inc., its investment advisor subsidiary registered with the Securities and Exchange Commission, AssetMark operates a platform that comprises fully integrated technology, personalized and scalable service and curated investment platform solutions designed to make a difference in the lives of advisors and their clients.
Contacts
Investors:
Taylor J. Hamilton, CFA
Head of Investor Relations
[email protected]
Media:
Alaina Kleinman
Head of PR & Communications
[email protected]
SOURCE: AssetMark Financial Holdings, Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gilead Sciences (GILD) Misses Q1 EPS by 288c
- CIDARA Therapeutics ALERT: Bragar Eagel & Squire, P.C. is Investigating Cidara Therapeutics, Inc. on Behalf of Cidara Therapeutics Stockholders and Encourages Investors to Contact the Firm
- LINCOLN ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Lincoln National Corporation and Encourages Investors to Contact the Firm
Create E-mail Alert Related Categories
Globe Newswire, Press ReleasesRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!